Di Bartolomeo, Maria <br/><br/>
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.  [electronic resource] 

 -  Oncology  2006 
 - 341-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000108575  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--adverse effects<br/>Chemotherapy, Adjuvant--adverse effects<br/>Cisplatin--administration & dosage<br/>Diarrhea--chemically induced<br/>Digestive System Surgical Procedures<br/>Disease-Free Survival<br/>Docetaxel<br/>Drug Administration Schedule<br/>Feasibility Studies<br/>Female<br/>Fluorouracil--adverse effects<br/>Humans<br/>Leucovorin--adverse effects<br/>Male<br/>Middle Aged<br/>Mitomycin--administration & dosage<br/>Neutropenia--chemically induced<br/>Prospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome